Mesenchymal Stem Cells in Central Nervous System injury2017

Central Nervous System Injury Clinical Trial

Official title: Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017

Status Active, not recruiting

Clinical Trial Summary

Central nervous system (CNS) injury leads to morbidity in patients, which has few good rehabilitation measures. Mesenchymal stem cells seem to have regenerative and tissue-repairing capabilities. The investigators design this study to infuse mesenchymal stem cells (MSCs) intrathecally to CNS injury patients, and observe the safety and efficacy by recording the change of nervous system scores, trying to prove the effect of MSC in rehabilitate CNS injury.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Central Nervous System Injury
• Trauma, Nervous System
• Wounds and Injuries

• NCT number: NCT03291366
• Study type: Interventional
• Source: Fuzhou General Hospital
• Status: Active, not recruiting
• Phase: Phase 1/Phase 2
• Start date: January 2017
• Completion date: January 2022